XBiotech Inc.
XBIT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001626878
No open-market purchases or sales by XBiotech Inc. insiders were filed in the last 90 days; 36 institutions reported holding it in 13F filings for Q2 2026, worth $4.56M in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in XBiotech Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 41
- −4 vs. Q3 2022
- Shares held
- 2.76M
- −302.3K (−9.9%) vs. Q3 2022
- Total value
- $9.68M
- −$1.40M (−12.6%) vs. Q3 2022
- New holders
- 1
- 7 more added
- Sold out
- 5
- 19 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting XBIT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 36 | $4.56M |
| Q1 2026 | 37 | $4.68M |
| Q4 2025 | 41 | $5.48M |
| Q3 2025 | 48 | $7.81M |
| Q2 2025 | 53 | $10.1M |
| Q1 2025 | 55 | $14.5M |
| Q4 2024 | 53 | $18.6M |
| Q3 2024 | 50 | $37.5M |
| Q2 2024 | 46 | $23.2M |
| Q1 2024 | 46 | $32.5M |
| Q4 2023 | 39 | $13.8M |
| Q3 2023 | 38 | $14.0M |
| Q2 2023 | 39 | $20.7M |
| Q1 2023 | 39 | $8.61M |
| Q4 2022 | 41 | $9.68M |
| Q3 2022 | 45 | $11.1M |
| Q2 2022 | 56 | $18.9M |
| Q1 2022 | 64 | $34.9M |
| Q4 2021 | 61 | $46.8M |
| Q3 2021 | 66 | $56.7M |
| Q2 2021 | 56 | $66.8M |
| Q1 2021 | 65 | $74.1M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding XBiotech Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 854,469 | $3.00M | 0.00% | +3520.0% | Added |
| BlackRock Inc. | 261,201 | $916.8K | 0.00% | +2,267+0.9% | Added |
| Credit Suisse AG | 245,270 | $860.9K | 0.00% | −18,438−7.0% | Reduced |
| Geode Capital Management, LLC | 155,083 | $544.0K | 0.00% | +3,342+2.2% | Added |
| Oasis Management Co Ltd. | 137,174 | $481.5K | 0.10% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 123,400 | $433.1K | 0.01% | −9,600−7.2% | Reduced |
| Renaissance Technologies LLC | 101,468 | $356.0K | 0.00% | −54,000−34.7% | Reduced |
| Morgan Stanley | 98,357 | $345.2K | 0.00% | −14,801−13.1% | Reduced |
| Dimensional Fund Advisors LP | 82,398 | $290.0K | 0.00% | −3,875−4.5% | Reduced |
| Two Sigma Investments, LP | 66,036 | $231.8K | 0.00% | −11,061−14.3% | Reduced |
| Connor, Clark & Lunn Investment Management Ltd. | 65,026 | $228.2K | 0.00% | −2,949−4.3% | Reduced |
| Two Sigma Advisers, LP | 59,600 | $209.2K | 0.00% | −9,700−14.0% | Reduced |
| State Street Corp | 57,295 | $201.1K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 55,693 | $195.5K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 52,244 | $183.0K | 0.00% | −85,743−62.1% | Reduced |
| Man Group plc | 49,013 | $172.0K | 0.00% | +31,713+183.3% | Added |
| Northern Trust Corp | 44,687 | $156.9K | 0.00% | −141−0.3% | Reduced |
| Acadian Asset Management LLC | 37,576 | $130.0K | 0.00% | −7,874−17.3% | Reduced |
| State of Wisconsin Investment Board | 25,000 | $87.8K | 0.00% | −4,706−15.8% | Reduced |
| Susquehanna Fundamental Investments, LLC | 20,863 | $73.2K | 0.00% | −537−2.5% | Reduced |
| FMR LLC | 20,280 | $71.2K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 18,734 | $65.8K | 0.00% | +11,391+155.1% | Added |
| Price T Rowe Associates Inc | 17,600 | $62.0K | 0.00% | 00.0% | Unchanged |
| D. E. Shaw & Co., Inc. | 15,052 | $52.8K | 0.00% | −33,097−68.7% | Reduced |
| Thomasville National Bank | 13,350 | $47.0K | 0.01% | 00.0% | Unchanged |
| HRT Financial LP | 13,279 | $46.0K | 0.00% | −27,708−67.6% | Reduced |
| Trexquant Investment LP | 12,985 | $45.6K | 0.00% | −8,990−40.9% | Reduced |
| Synovus Financial Corp | 11,796 | $41.4K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 11,725 | $41.2K | 0.00% | +11,725 | New |
| Charles Schwab Investment Management Inc | 10,477 | $36.8K | 0.00% | 00.0% | Unchanged |
| LGT Fund Management Co Ltd. | 10,000 | $35.1K | 0.02% | 00.0% | Unchanged |
| UBS Group AG | 5,897 | $20.7K | 0.00% | +614+11.6% | Added |
| Royal Bank of Canada | 2,000 | $7.00K | 0.00% | 00.0% | Unchanged |
| McIlrath & Eck, LLC | 753 | $2.64K | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 400 | $1.40K | 0.00% | −1,626−80.3% | Reduced |
| Tower Research Capital LLC (TRC) | 171 | $1.00K | 0.00% | −2,400−93.3% | Reduced |
| IFP Advisors, Inc | 200 | $1.00K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 350 | $1.00K | 0.00% | 00.0% | Unchanged |
| Financial Connections Group, Inc. | 500 | $1.00K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 120 | $421 | 0.00% | +3+2.6% | Added |
| JPMorgan Chase & Co | 38 | $0 | 0.00% | −11,098−99.7% | Reduced |
| RBF Capital, LLC | 0 | $0 | 0.00% | −23,172−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −12,591−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −10,439−100.0% | Sold out |
| ETF Managers Group, LLC | 0 | $0 | 0.00% | −8,982−100.0% | Sold out |
| Capital Advisors, Ltd. LLC | 0 | $0 | 0.00% | −209−100.0% | Sold out |